Novartis To Topple Teva As World's Largest Generics Maker
Swiss drug maker Novartis' acquisition of Hexal in Germany and Eon Labs in the U.S. for a total of more than $8 billion will create the world's largest generics drug maker,...To view the full article, register now.
Already a subscriber? Click here to view full article